Navigation Links


bromouridine in other areas

bromouridine - Wiktionary

bromouridine. Definition from Wiktionary, a free dictionary. Jump to: navigation, search ... Retrieved from "http://en.wiktionary.org/wiki/bromouridine" ...

Organic : 5-Bromouridine

Laboratory equipment and supplies, including 5-Bromouridine. Choose from 250,000 laboratory supplies. ... 5-Bromouridine. Chemical Formula: C9H11BrN2O6 ...

An RNA-protein contact determined by 5-bromouridine substitution ...

... R17, that contains a 5-bromouridine at position -5 (RNA 1), complexes ... specific, UV-induced RNA-protein cross-link using 5-bromouridine-substituted RNA. ...

The cell cycle effects and induction of apoptosis by 5-bromouridine in ...

5-Bromouridine (BrUrd) and several analogues of this antimetabolite exhibit ... and induction of apoptosis by 5-bromouridine in cultures of human leukaemic MOLT ...

MSDS.BB0246-5-Bromouridine

PRODUCT NAME (-)-5-BROMOURIDINE, 98% PRODUCT NUMBER BB0246 ... SYNONYMS 5-BROMOURIDINE * 1-BETA-RIBOFURANOSYL-5-BROMO-URACIL. RTECS NUMBER: YU7300000 ...

fisherSci.com - 5-Bromouridine 99+%, Acros Organics - 780699

Fisher ... For security reasons you will be automatically logged out after 30 ... 5-Bromouridine 99+%, Acros Organics. 5-Bromouridine. 99+% 99 ...
Other Tagsblues
Breaking Biology News(10 mins):$2.4 million stimulus fuels effort to regenerate injured spinal cords 2$2.4 million stimulus fuels effort to regenerate injured spinal cords 3$2.4 million stimulus fuels effort to regenerate injured spinal cords 4Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences 2List of 'unsung' wildlife affected by climate change released 2XRC Medical Imaging Announces Rapid Test Results 14182 1XRC Medical Imaging Announces Rapid Test Results 14182 2Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 1Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 2Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 3Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 4Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 5Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 6Dalton Pharma Services Adds Formulation Development Services 57793 1Dalton Pharma Services Adds Formulation Development Services 57793 2
Other Contentsunicellularunicellularunicellularregionregionregionregionregionregionregionregionregionunlinkeduntranslateduntranslatedupperupperupperupperupperupperupperupperupperupperupstreamupstreamupstreamupstreamupstreamuraciluraciluracil